Co-Diagnostics Inc (CODX)

$2.57 -0.04 (-1.53%)
Market Cap 9.62M
Revenue (ttm) 620,000.00
Net Income (ttm) -46.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7,564.52%
Debt to Equity Ratio 0.00
Volume 67,400
Avg Vol 7,143,790
Day's Range N/A - N/A
Shares Out 3.69M
Stochastic %K 5%
Beta 2.84
Analysts Hold
Price Target $45.00

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, hum...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 438 1036
Website: co-dx.com
Address:
2401 S. Foothill Drive, Suite D, Salt Lake City, United States
Minutiae
Minutiae Jul. 15 at 5:15 AM
$CODX Jul 14 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx
0 · Reply
Minutiae
Minutiae Jul. 15 at 5:14 AM
$CODX Jul 14 CODX volume 67,874 closing at $2.57. 1,670 after-hour shares trading at $2.53 to $2.62. FINRA Short Sale Volume 17,668 shorted shares out of 29,054. CODX short volume 61%. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting
0 · Reply
mexx
mexx Jul. 14 at 8:43 PM
$CODX I've most likely been sick with the BA.3.2 variant for three weeks, but how am I supposed to confirm it when PCR tests aren't even available? I have all the symptoms. You fucked up, Dwight.
2 · Reply
NetworkNewsWire
NetworkNewsWire Jul. 14 at 7:49 PM
Expert Highlights Growing Evidence That Links Respiratory Infections to Cardiovascular Diseases $CODX #BioMed #Diseases https://ibn.fm/O1epi
0 · Reply
LuigiV_
LuigiV_ Jul. 14 at 7:48 PM
$LABT $CODX $EZRA $SMSI takn
0 · Reply
Eaa125
Eaa125 Jul. 14 at 5:36 PM
$KMRK needs volume and then can make a big run! $CODX $BYND
0 · Reply
Eaa125
Eaa125 Jul. 14 at 1:58 PM
Morning Watchers: $BMNR $KMRK $CODX $BYND
0 · Reply
Pyranha
Pyranha Jul. 14 at 10:37 AM
$CODX genuinely baffles me how Dwight projected end of May for TB trials. He was either lying about when it would start as to keep investors on their toes or something is delaying it. Not sure what type of delay could occur that would take us 45 days over due date if he was expecting starting by End of May.
3 · Reply
Antiquarian
Antiquarian Jul. 14 at 10:24 AM
$CODX https://simpler.grants.gov/opportunity/e9cc2af5-8322-4e22-8566-82835e32ec30
1 · Reply
Antiquarian
Antiquarian Jul. 14 at 10:21 AM
$CODX Maybe we will see this section have some additions to it. That would be nice https://co-dx.com/awards-and-grants/
1 · Reply
Latest News on CODX
Co-Diagnostics Proxy statement: Proxy filing

Jul 10, 2026, 8:00 AM EDT - 5 days ago

Co-Diagnostics Proxy statement: Proxy filing

Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand

Jul 8, 2026, 9:00 AM EDT - 7 days ago

Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand

Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test

Jul 1, 2026, 9:00 AM EDT - 14 days ago

Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test

Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States

Jun 25, 2026, 9:00 AM EDT - 20 days ago

Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States

Co-Diagnostics signs distribution agreement for CO-Dx PCR Pro in Mexico

2026-06-11T13:08:40.000Z - 4 weeks ago

Co-Diagnostics signs distribution agreement for CO-Dx PCR Pro in Mexico

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement

Jun 11, 2026, 9:00 AM EDT - 4 weeks ago

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement

Co-Diagnostics announces continued progress in Ebola PCR development program

2026-06-02T14:52:18.000Z - 6 weeks ago

Co-Diagnostics announces continued progress in Ebola PCR development program

Co-Diagnostics trading halted, volatility trading pause

2026-06-02T14:07:28.000Z - 6 weeks ago

Co-Diagnostics trading halted, volatility trading pause

Co-Diagnostics trading resumes

2026-06-02T13:54:50.000Z - 6 weeks ago

Co-Diagnostics trading resumes

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Jun 2, 2026, 9:00 AM EDT - 6 weeks ago

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Co-Diagnostics files to sell 4.94M shares of common stock for holders

2026-05-28T21:18:09.000Z - 6 weeks ago

Co-Diagnostics files to sell 4.94M shares of common stock for holders

Co-Diagnostics Registration statement: Registration filing

May 28, 2026, 8:00 AM EDT - 6 weeks ago

Co-Diagnostics Registration statement: Registration filing

Co-Diagnostics trading halted, volatility trading pause

2026-05-27T15:15:44.000Z - 6 weeks ago

Co-Diagnostics trading halted, volatility trading pause

Co-Diagnostics trading resumes

2026-05-27T15:08:07.000Z - 6 weeks ago

Co-Diagnostics trading resumes

Co-Diagnostics and CoSara Diagnostics advance with ebola PCR development

2026-05-26T14:04:46.000Z - 7 weeks ago

Co-Diagnostics and CoSara Diagnostics advance with ebola PCR development

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

May 26, 2026, 9:00 AM EDT - 7 weeks ago

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

May 19, 2026, 10:54 PM EDT - 2 months ago

Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics develops ebola assay strategy after recent global outbreak alert

2026-05-19T13:16:13.000Z - 2 months ago

Co-Diagnostics develops ebola assay strategy after recent global outbreak alert

Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

May 19, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

Co-Diagnostics reports Q1 EPS ($4.06) vs. ($7.05) last year

2026-05-14T21:49:36.000Z - 2 months ago

Co-Diagnostics reports Q1 EPS ($4.06) vs. ($7.05) last year

Co-Diagnostics Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 2 months ago

Co-Diagnostics Earnings Call Transcript: Q1 2026

Co-Diagnostics Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 2 months ago

Co-Diagnostics Earnings release: Q1 2026

Co-Diagnostics Quarterly report: Q1 2026

May 14, 2026, 4:30 PM EDT - 2 months ago

Co-Diagnostics Quarterly report: Q1 2026

Co-Diagnostics Reports First Quarter 2026 Financial Results

May 14, 2026, 4:01 PM EDT - 2 months ago

Co-Diagnostics Reports First Quarter 2026 Financial Results

Co-Diagnostics Slides: Investor presentation

May 14, 2026, 4:00 PM EDT - 2 months ago

Co-Diagnostics Slides: Investor presentation

Co-Diagnostics files $150M mixed securities shelf

2026-05-12T20:55:31.000Z - 2 months ago

Co-Diagnostics files $150M mixed securities shelf

Co-Diagnostics Registration statement: Registration filing

May 12, 2026, 8:00 AM EDT - 2 months ago

Co-Diagnostics Registration statement: Registration filing

Co-Diagnostics’ joint venture with CoMira finalizes facility lease agreement

2026-05-08T15:28:11.000Z - 2 months ago

Co-Diagnostics’ joint venture with CoMira finalizes facility lease agreement

Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City

May 8, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City

Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast

Apr 30, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast

Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.

Apr 16, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

Apr 14, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah

Apr 9, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah

Co-Diagnostics Earnings Call Transcript: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 3 months ago

Co-Diagnostics Earnings Call Transcript: Q4 2025

Co-Diagnostics Annual report: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 3 months ago

Co-Diagnostics Annual report: Q4 2025

Co-Diagnostics Earnings release: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 3 months ago

Co-Diagnostics Earnings release: Q4 2025

Co-Diagnostics Reports Full Year 2025 Financial Results

Mar 31, 2026, 4:01 PM EDT - 3 months ago

Co-Diagnostics Reports Full Year 2025 Financial Results

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

Mar 25, 2026, 8:00 AM EDT - 4 months ago

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

Co-Diagnostics to expand commercial, distribution territory across South Asia

2026-03-20T12:11:57.000Z - 4 months ago

Co-Diagnostics to expand commercial, distribution territory across South Asia

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

Mar 20, 2026, 8:00 AM EDT - 4 months ago

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Mar 17, 2026, 9:00 AM EDT - 4 months ago

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Co-Diagnostics to Present at Medical Korea 2026

Mar 16, 2026, 9:00 AM EDT - 4 months ago

Co-Diagnostics to Present at Medical Korea 2026

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

Mar 12, 2026, 9:00 AM EDT - 4 months ago

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

Mar 10, 2026, 9:00 AM EDT - 4 months ago

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Feb 9, 2026, 9:00 AM EST - 5 months ago

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Feb 5, 2026, 9:00 AM EST - 5 months ago

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Feb 4, 2026, 9:00 AM EST - 5 months ago

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Co-Diagnostics cut to Hold at Maxim on Nasdaq delisting

2026-01-23T14:10:52.000Z - 6 months ago

Co-Diagnostics cut to Hold at Maxim on Nasdaq delisting

Co-Diagnostics downgraded to Hold from Buy at Maxim

2026-01-23T13:00:47.000Z - 6 months ago

Co-Diagnostics downgraded to Hold from Buy at Maxim

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Jan 12, 2026, 9:00 AM EST - 6 months ago

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Co-Diagnostics Announces Reverse Stock Split

Dec 30, 2025, 9:00 AM EST - 7 months ago

Co-Diagnostics Announces Reverse Stock Split

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Dec 29, 2025, 9:00 AM EST - 7 months ago

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Dec 18, 2025, 9:00 AM EST - 7 months ago

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Dec 17, 2025, 9:00 AM EST - 7 months ago

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

Dec 9, 2025, 9:00 AM EST - 7 months ago

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Dec 8, 2025, 12:36 PM EST - 7 months ago

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Nov 20, 2025, 9:00 AM EST - 8 months ago

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Nov 18, 2025, 9:00 AM EST - 8 months ago

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Co-Diagnostics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

Co-Diagnostics Earnings Call Transcript: Q3 2025

Co-Diagnostics Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

Co-Diagnostics Quarterly report: Q3 2025

Co-Diagnostics Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

Co-Diagnostics Earnings release: Q3 2025

Co-Diagnostics Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 4:01 PM EST - 8 months ago

Co-Diagnostics Reports Third Quarter 2025 Financial Results

Co-Diagnostics Proxy statement: Proxy Filing

Nov 10, 2025, 7:00 AM EST - 8 months ago

Co-Diagnostics Proxy statement: Proxy Filing

Co-Diagnostics Transcript: Fireside Chat

Nov 5, 2025, 11:00 AM EST - 8 months ago

Co-Diagnostics Transcript: Fireside Chat

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

Nov 5, 2025, 9:00 AM EST - 9 months ago

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Nov 3, 2025, 9:00 AM EST - 9 months ago

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Oct 31, 2025, 9:00 AM EDT - 9 months ago

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Co-Diagnostics Proxy statement: Proxy Filing

Oct 31, 2025, 8:00 AM EDT - 9 months ago

Co-Diagnostics Proxy statement: Proxy Filing

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Oct 30, 2025, 1:57 PM EDT - 9 months ago

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 29, 2025, 12:51 PM EDT - 9 months ago

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 28, 2025, 9:33 AM EDT - 9 months ago

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Oct 22, 2025, 8:30 AM EDT - 9 months ago

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

Oct 16, 2025, 9:30 AM EDT - 9 months ago

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Oct 13, 2025, 9:30 AM EDT - 9 months ago

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Co-Diagnostics Transcript: Lytham Partners Fall 2025 Investor Conference

Sep 30, 2025, 4:15 PM EDT - 10 months ago

Co-Diagnostics Transcript: Lytham Partners Fall 2025 Investor Conference

Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30

Sep 30, 2025, 9:30 AM EDT - 10 months ago

Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 18, 2025, 5:05 PM EDT - 10 months ago

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 17, 2025, 9:47 AM EDT - 10 months ago

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains

Sep 11, 2025, 9:30 AM EDT - 10 months ago

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains

Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

Sep 9, 2025, 9:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

Aug 18, 2025, 9:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

Co-Diagnostics Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Co-Diagnostics Earnings Call Transcript: Q2 2025

Co-Diagnostics Quarterly report: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Co-Diagnostics Quarterly report: Q2 2025

Co-Diagnostics Earnings release: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 11 months ago

Co-Diagnostics Earnings release: Q2 2025

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 4:01 PM EDT - 11 months ago

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results

Minutiae
Minutiae Jul. 15 at 5:15 AM
$CODX Jul 14 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx
0 · Reply
Minutiae
Minutiae Jul. 15 at 5:14 AM
$CODX Jul 14 CODX volume 67,874 closing at $2.57. 1,670 after-hour shares trading at $2.53 to $2.62. FINRA Short Sale Volume 17,668 shorted shares out of 29,054. CODX short volume 61%. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting
0 · Reply
mexx
mexx Jul. 14 at 8:43 PM
$CODX I've most likely been sick with the BA.3.2 variant for three weeks, but how am I supposed to confirm it when PCR tests aren't even available? I have all the symptoms. You fucked up, Dwight.
2 · Reply
NetworkNewsWire
NetworkNewsWire Jul. 14 at 7:49 PM
Expert Highlights Growing Evidence That Links Respiratory Infections to Cardiovascular Diseases $CODX #BioMed #Diseases https://ibn.fm/O1epi
0 · Reply
LuigiV_
LuigiV_ Jul. 14 at 7:48 PM
$LABT $CODX $EZRA $SMSI takn
0 · Reply
Eaa125
Eaa125 Jul. 14 at 5:36 PM
$KMRK needs volume and then can make a big run! $CODX $BYND
0 · Reply
Eaa125
Eaa125 Jul. 14 at 1:58 PM
Morning Watchers: $BMNR $KMRK $CODX $BYND
0 · Reply
Pyranha
Pyranha Jul. 14 at 10:37 AM
$CODX genuinely baffles me how Dwight projected end of May for TB trials. He was either lying about when it would start as to keep investors on their toes or something is delaying it. Not sure what type of delay could occur that would take us 45 days over due date if he was expecting starting by End of May.
3 · Reply
Antiquarian
Antiquarian Jul. 14 at 10:24 AM
$CODX https://simpler.grants.gov/opportunity/e9cc2af5-8322-4e22-8566-82835e32ec30
1 · Reply
Antiquarian
Antiquarian Jul. 14 at 10:21 AM
$CODX Maybe we will see this section have some additions to it. That would be nice https://co-dx.com/awards-and-grants/
1 · Reply
Antiquarian
Antiquarian Jul. 14 at 10:15 AM
$CODX https://youtu.be/ZG15oP7q4fI?si=nl7vEyv7ka_qDxzy
0 · Reply
Antiquarian
Antiquarian Jul. 14 at 10:09 AM
$CODX .
0 · Reply
Antiquarian
Antiquarian Jul. 14 at 10:09 AM
$CODX
0 · Reply
Antiquarian
Antiquarian Jul. 14 at 10:08 AM
$CODX Co-Dx now has 4 job openings: Project Manager Medical Device Mechanical Engineer Software Engineer Quality Engineer https://www.indeed.com/q-co-diagnostics-l-salt-lake-city,-ut-jobs.html
1 · Reply
Antiquarian
Antiquarian Jul. 14 at 10:07 AM
$CODX July 13 full day chart https://www.nasdaq.com/market-activity/stocks/codx
0 · Reply
Antiquarian
Antiquarian Jul. 14 at 10:06 AM
$CODX Jul 13 CODX volume 110,172 closing at $2.61. 1,320 after-hour shares trading at $2.535 to $2.61. FINRA Short Sale Volume 15,167 shorted shares out of 38,080. CODX short volume 40%. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting
0 · Reply
Minutiae
Minutiae Jul. 14 at 7:49 AM
$CODX Co-Dx now has 4 job openings: Project Manager Medical Device Mechanical Engineer Software Engineer Quality Engineer https://www.indeed.com/q-co-diagnostics-l-salt-lake-city,-ut-jobs.html?vjk=c531438df780c96e
0 · Reply
Minutiae
Minutiae Jul. 14 at 7:21 AM
$CODX Jul 13 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx
0 · Reply
Minutiae
Minutiae Jul. 14 at 7:20 AM
$CODX Jul 13 CODX volume 110,172 closing at $2.61. 1,320 after-hour shares trading at $2.535 to $2.61. FINRA Short Sale Volume 15,167 shorted shares out of 38,080. CODX short volume 40%. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting
0 · Reply
Jonboy33
Jonboy33 Jul. 13 at 10:56 PM
$CODX
0 · Reply
Minutiae
Minutiae Jul. 13 at 10:08 PM
$CODX Co-Diagnostics, Inc’s Linkedin Post Posted Jul 13, 2026, 3h ago "Tuberculosis has been a global public health concern for thousands of years. Overcoming TB will require new ways of thinking, new ways of acting, and new ways of working together." "It was an honor to be in Bangkok as one of just 5 manufacturer partners invited to the Global Implementation Workshop on Near Point of Care (NPOC) TB Diagnostics last week, and to share our vision of the role we hope to play in increasing the availability of #NPOC testing for #TB." https://www.linkedin.com/posts/codiagnostics-inc_npoc-tb-activity-7482494819735449600-hk8H
1 · Reply
Antiquarian
Antiquarian Jul. 13 at 7:47 PM
$CODX Posted 1 hour ago on LinkedIn “Tuberculosis has been a global public health concern for thousands of years. Overcoming TB will require new ways of thinking, new ways of acting, and new ways of working together. It was an honor to be in Bangkok as one of just 5 manufacturer partners invited to the Global Implementation Workshop on Near Point of Care (NPOC) TB Diagnostics last week, and to share our vision of the role we hope to play in increasing the availability of NPOC testing for TB.” https://www.linkedin.com/posts/codiagnostics-inc_npoc-tb-activity-7482494819735449600-hk8H?utm_medium=ios_app&rcm=ACoAAFjXGZcBhXwZH9_iFWZo5edPFCgnaenwTFM&utm_source=social_share_send&utm_campaign=copy_link
2 · Reply